Bayer AG (BAYZF)
57.35
+1.18
(+2.09%)
USD |
OTCM |
Aug 25, 16:00
Bayer Debt to Equity Ratio : 1.299 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.299 |
| March 31, 2026 | 1.348 |
| December 31, 2025 | 1.443 |
| September 30, 2025 | 1.340 |
| June 30, 2025 | 1.265 |
| March 31, 2025 | 1.214 |
| December 31, 2024 | 1.277 |
| September 30, 2024 | 1.347 |
| June 30, 2024 | 1.305 |
| March 31, 2024 | 1.300 |
| December 31, 2023 | 1.360 |
| September 30, 2023 | 1.421 |
| June 30, 2023 | 1.259 |
| March 31, 2023 | 1.060 |
| December 31, 2022 | 1.069 |
| September 30, 2022 | 1.085 |
| June 30, 2022 | 1.174 |
| March 31, 2022 | 1.136 |
| December 31, 2021 | 1.236 |
| September 30, 2021 | 1.343 |
| June 30, 2021 | 1.329 |
| March 31, 2021 | 1.239 |
| December 31, 2020 | 1.364 |
| September 30, 2020 | 1.387 |
| June 30, 2020 | 1.157 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.8231 |
| December 31, 2019 | 0.8247 |
| September 30, 2019 | 0.9543 |
| June 30, 2019 | 0.9695 |
| March 31, 2019 | 0.881 |
| December 31, 2018 | 0.8966 |
| September 30, 2018 | 0.8731 |
| June 30, 2018 | 1.106 |
| March 31, 2018 | 0.3662 |
| December 31, 2017 | 0.3732 |
| September 30, 2017 | 0.4333 |
| June 30, 2017 | 0.5882 |
| March 31, 2017 | 0.5648 |
| December 31, 2016 | 0.6236 |
| September 30, 2016 | 0.822 |
| June 30, 2016 | 0.8675 |
| March 31, 2016 | 0.8597 |
| December 31, 2015 | 0.79 |
| September 30, 2015 | 1.013 |
| June 30, 2015 | 1.112 |
| March 31, 2015 | 1.077 |
| December 31, 2014 | 1.055 |
| September 30, 2014 | 0.7187 |
| June 30, 2014 | 0.5963 |
| March 31, 2014 | 0.5828 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Merck KGaA | 0.4077 |
| Breakthrough Chemistry, Inc. | 0.2335 |
| Cardiac Biotech Solutions, Inc. | -0.2375 |
| Fresenius SE & Co. KGaA | 0.5796 |
| Carl Zeiss Meditec AG | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 122.66B |
| Total Liabilities (Quarterly) | 88.69B |
| Shareholders Equity (Quarterly) | 33.82B |
| Current Ratio | 1.043 |
| Net Debt Paydown Yield | -0.52% |